Inologic Receives $1.1 Million Department of Defense Government Contract to Develop Radioprotective Drugs, January 17, 2007
Inologic appoints Dr. Langton-Webster as Chief Operating Officer, June 1, 2005
Inologic awarded 2-year Small Business Development Grant from the National Institutes of Health, August 22, 2005
Inologic Receives Award at Springboard: Silicon Valley 2004 Venture Capital Forum, June 24, 2004
Inologic Achieves Second Milestone in its Award from the Cystic Fibrosis Foundation Therapeutics, April 16, 2004
Inologic Achieves First Milestone in its Award from the Cystic Fibrosis Foundation Therapeutics, December 2, 2003
Inologic Presents Promising Data at the Seventeenth Annual North American Cystic Fibrosis Conference, October 16, 2003
FDA Grants Orphan Drug Status to Inologic's Lead CF Compound, August 27, 2003
Inologic Receives $1.5 Million Award from Cystic Fibrosis Foundation Therapeutics, February 27, 2003
Inologic Awarded National Institute of Health Funded Research Grant, November 6, 2002
Inologic Appoints Beatrice Langton-Webster as Vice President, Drug Development, May 8, 2002
